Saisai Xie Selected Research

valyl-valyl-tyrosyl-proline

1/2021

Val-Val-Tyr-Pro protects against non-alcoholic steatohepatitis in mice by modulating the gut microbiota and gut-liver axis activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saisai Xie Research Topics

Disease

1	Infections 10/2021
1	Peritonitis 10/2021
1	Sepsis (Septicemia) 10/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Colitis 01/2021
1	Alcoholic Fatty Liver 01/2021
1	Uveal melanoma 11/2019
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Neoplasms (Cancer) 11/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018

Drug/Important Bio-Agent (IBA)

1	Polymyxin B (Aerosporin)FDA LinkGeneric 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	LipopeptidesIBA 10/2021
1	Peptides (Polypeptides)IBA 10/2021
1	valyl-valyl-tyrosyl-prolineIBA 01/2021
1	LipidsIBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	AcidsIBA 01/2021
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2021
1	Protective AgentsIBA 01/2021
1	Insulin (Novolin)FDA Link 11/2019
1	celastrol methyl esterIBA 11/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	pyrimidineIBA 01/2018